BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer

Rafael Rosell, Marcin Skrzypski, Ewa Jassem et al. · 2007

Read BRCA1: A Novel Prognostic Factor in Resected Non-Small-Cell Lung Cancer by Rafael Rosell, Marcin Skrzypski, Ewa Jassem et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001129.txt.

Description

Early-stage lung cancer can be cured by surgery, yet patients at the same stage often fare very differently. Rafael Rosell and co-authors looked for a gene that helps explain that spread, in a 2007 PLOS ONE article. Their candidate was BRCA1, a gene better known from breast and ovarian cancer.

The study covers non-small-cell lung cancer that was removed by surgery. Gene expression profiles can sort patients into groups with different outlooks even within one stage. The authors present BRCA1 as a new prognostic factor, meaning its levels carry information about likely survival. Such markers could one day guide who needs extra treatment after surgery.

Catalog record

CREATORRafael Rosell, Marcin Skrzypski, Ewa Jassem et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001129

Browse the full library · About the Tower of Babel